Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica
Nanox Imaging signed a distribution agreement with Costa Rica-based SOLME RC, S.A. to market, install, and support the Nanox.ARC multi-source digital tomosynthesis system in Costa Rica.
Costa Rica is Nanox's third Latin American market this year, following Argentina and Peru; SOLME is a registered supplier to CCSS, the country's principal purchaser and provider of hospital services.
Commercialization must first clear Costa Rica's regulatory registration process, including an initial six-month POC device registration period, and no financial terms of the agreement were disclosed.